Downstream Processing Featured Articles

  1. Samsung Bioepis And MSD Enter Biosimilars Development And Commercialization Agreement 2/20/2013

    Samsung Bioepis Co., Ltd. and MSD, known as Merck in the United States and Canada, announced
    today they have entered into an agreement to develop and commercialize multiple pre-
    specified and undisclosed biosimilar candidates.

  2. 'Different Kind Of Stem Cell' Possesses Attributes Favoring Regenerative Medicine 11/21/2012

    A research team at Georgetown Lombardi Comprehensive Cancer Center say the new and powerful cells they first created in the laboratory a year ago constitute a new stem-like state of adult epithelial cells.

  3. Investigational Brain Cancer Vaccine To Be Tested In Phase I Roswell Park Study 9/27/2012

    A new clinical research study at Roswell Park Cancer Institute(RPCI) will test a first-of-its-kind cancer “vaccine” that may prove effective against many forms of solid-tumor cancers.

  4. RNA-Based Therapy Brings New Hope For An Incurable Blood Cancer 10/10/2012

    Three thousand new cases of Mantle Cell Lymphoma (MCL), a form of blood cancer, appear in the United States each year. With a median survival span of only five to seven years, according to the Leukemia and Lymphoma Society, this disease is devastating, and new therapies are sorely needed.

  5. Whitehead Scientists Identify Major Flaw In Standard Approach To Global Gene Expression Analysis 10/25/2012

    Whitehead Institute researchers report that common assumptions employed in the generation and interpretation of data from global gene expression analyses can lead to seriously flawed conclusions about gene activity and cell behavior in a wide range of current biological research. By Nicole Giese Rura

  6. Cortex Biochem Awarded Patent 6/9/2005
    Cortex Biochem(TM) Inc., a global leader in developing magnetic particle technology and products used in genomic research and clinical diagnostics, announced it has received a U.S. patent for its MagaZorb(R) Nucleic Acid (DNA/RNA) Isolation and Purification System...
  7. Frost & Sullivan: Biosimilars Market Expected To Soar 2/14/2013

    Top representatives from the healthcare industry are confirmed to attend the 2nd Biosimilars Congregation which will take place in London on the 19th and 20th of February 2013. Ranjith Gopinathan, Frost & Sullivan Program Manager for Life Sciences, Europe Practice is set to participate to the event’s Keynote Panel Discussion focusing on challenges and opportunities in the global biosimilars market.

  8. FlexFill Single-Use Transfer Assembly 10/3/2011
    Meissner introduces its new FlexFill single-use biocontainer transfer assembly. The assembly is ideally suited for applications requiring fast and dependable aseptic transfer of small liquid process volumes.
  9. New LIAISON Ixt/Arrow CellSep Advanced Provides Rapid, Automated Cell Separation For Up To Three Cell Types In A Single Run 4/29/2014

    DiaSorin has launched LIAISON Ixt/Arrow CellSep Advanced for the automated isolation of cells directly from whole blood or buffy coat.

  10. Critical Innovation Bioprocessing Trends For 2014 12/12/2013

    How the most critical innovations will affect the industry future with the efforts to reduce the costs of manufacturing a biologic, according to the 10th Annual Report and Survey of Biopharmaceutical Manufacturers.